| Application no. and date | 19824223.2 (espacenet) (Federated) (European Patent Register), 20191129 | | Patent/reg. no. and date | DK/EP 3886894, 20240313 | | Publication date | 20211006 | | Priority no. and date | US 201862774168 P, 20181130, US 201862774858 P, 20181203, US 201962847897 P, 20190514, US 201962854957 P, 20190530, US 201962931143 P, 20191105 | | EP pub. no. and date |
EP 3886894 20211006 | | Effective date | | | Applicant/owner | Juno Therapeutics, Inc., 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109-4703, US | | Applicant ref. no. | | | Inventor | GILLENWATER, Heidi, c/o Juno Therapeutics, Inc. 400 Dexter Ave. N
Suite 1200
Seattle, Washington 98109-4703, US,
ALBERTSON, Tina, 400 Dexter Ave. N Suite 1200
Seattle, Washington 98109, US,
DUBOVSKY, Jason A., 400 Dexter Ave. N Suite 1200
Seattle, Washington 98109, US,
THORPE, Jerill, 400 Dexter Ave. N Suite 1200
Seattle, Washington 98109, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 35/17 (2015.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 14/05 (2006.01) , C12N 5/0783 (2010.01) | | Title | FREMGANGSMÅDER TIL DOSERING OG BEHANDLING AF B-CELLEMALIGNITETER I
ADOPTIV CELLETERAPI | | Int. application no. | US2019063883 | | Int. publication no. | WO2020113188 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
